Suppr超能文献

百汇医疗®胃内球囊(BIB®)。单中心西班牙经验,714 例连续患者接受一个或两个连续球囊治疗。

BioEnterics® intragastric balloon (BIB®). Single ambulatory center Spanish experience with 714 consecutive patients treated with one or two consecutive balloons.

机构信息

Department of Digestive and Endoscopy, Madrid Sanchinarro University Hospital, C/Padre Arrupe 89, Chalet, 28050 Madrid, Spain.

出版信息

Obes Surg. 2011 Jan;21(1):5-9. doi: 10.1007/s11695-010-0093-3. Epub 2010 Mar 20.

Abstract

BACKGROUND

The BioEnterics® Intragastric Balloon (BIB®) is a well-established device for temporary treatment in morbidly obese patients. The aim of this study is the evaluation, in a population of 714 consecutive outpatient setting cases, BIB® results in terms of weight loss and comorbidity change.

METHODS

BIB® was positioned in all cases after diagnostic endoscopy. The device was inflated under direct endoscopic vision with saline solution (600-700 ml) and methylene blue (10 ml). Intubation was carried out in patients with body mass index (BMI) > 40 kg/m(2) affected by sleep apnea or chronic obstructive pulmonary disease. After 6 months, balloon removal was carried out, and patients were discharged with drug therapy and 1,000 kcal diet. More than 100 patients underwent a second consecutive balloon positioning. One month from the removal of the first BIB, patients were given a second BIB. Patients were followed up weekly. Mortality, complications and their treatment, postplacement symptoms, comorbidities, BMI, percentage of excess BMI loss (%EBL), and percentage of excess weight loss (%EWL) were considered. Data are expressed as mean ± standard deviation.

RESULTS

From June 1, 2005, to May 31, 2007, 714 patients underwent BIB® placement (143 males/571 females; mean age, 38.4 ± 16.1; mean BMI, 37.6 ± 5.7 kg/m(2); mean EW, 56.3 ± 27.1 kg). After 6 months, mean BMI was 31.1 ± 7.2, mean %EWL was 41.6 ± 21.8, mean BMI loss was 6.5 ± 12.7, and mean %EBL was 44.5 ± 22.6. Of 714 patients, 112 underwent a second BIB placement. At the time of the second balloon placement, mean BMI was 32.9 ± 6.7 kg/m(2); range was 31-51. After the second balloon removal, mean BMI was 30.3 ± 7.2.

CONCLUSIONS

BIB® treatment is a safe and effective procedure for weight reduction, without mortality and with very low morbidity rates even in nonhospitalized patients. A second balloon can also be positioned without difficulties, achieving good results after 12 months of treatment.

摘要

背景

BioEnterics® 胃内球囊(BIB®)是一种成熟的设备,可用于治疗病态肥胖患者。本研究的目的是评估 714 例连续门诊病例中 BIB®在体重减轻和合并症变化方面的结果。

方法

在所有病例中,在诊断内镜检查后放置 BIB®。用生理盐水(600-700 毫升)和亚甲蓝(10 毫升)在直视内镜下将球囊充气。对于 BMI>40kg/m2 的患者,在患有睡眠呼吸暂停或慢性阻塞性肺病的情况下进行插管。6 个月后,取出气球,并为患者提供药物治疗和 1000 卡路里的饮食。100 多名患者进行了第二次连续球囊定位。第一次 BIB 取出后一个月,给患者第二次 BIB。每周对患者进行随访。考虑死亡率、并发症及其治疗、放置后症状、合并症、BMI、多余体重减轻百分比(%EWL)和多余体重指数减轻百分比(%EBL)。数据以平均值±标准差表示。

结果

从 2005 年 6 月 1 日至 2007 年 5 月 31 日,714 例患者接受了 BIB®放置(143 例男性/571 例女性;平均年龄 38.4±16.1 岁;平均 BMI 37.6±5.7kg/m2;平均体重 56.3±27.1kg)。6 个月后,平均 BMI 为 31.1±7.2,平均 EWL%为 41.6±21.8,平均 BMI 下降 6.5±12.7,平均 EBL%为 44.5±22.6。714 例患者中有 112 例接受了第二次 BIB 放置。在第二次球囊放置时,平均 BMI 为 32.9±6.7kg/m2;范围为 31-51。第二次球囊取出后,平均 BMI 为 30.3±7.2。

结论

BIB®治疗是一种安全有效的减肥方法,无死亡率,即使是非住院患者,发病率也很低。也可以无困难地定位第二个气球,在 12 个月的治疗后获得良好的效果。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验